BOSTON SCIENTIFIC CORP vs WEST PHARMACEUTICAL SERVICES, INC., two Medical Devices stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where BSX and WST diverge most: on debt / equity, BSX reads 0.00 and WST reads 0.07; on p/b, BSX reads 2.68 and WST reads 8.13. The rest of the comparable metrics sit closer together. What BSX's price implies is a bet that sits within the historical range (whole-company basis). What WST's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | BSX | WST |
|---|---|---|
| Price | $46.73 | $341.01 |
| Market cap | $69.9B | $24.3B |
| Sector | Medical Devices | Medical Devices |
| Stage | Growth | Mature |
| Implied growth (priced in) | +4.1% | — |
| P/E | 19.6 | 43.7 |
| P/B | 2.68 | 8.13 |
| P/S | 3.39 | 7.31 |
| EV/EBITDA | 13.2 | 27.9 |
| Revenue growth | +17.6% | +12.5% |
| Gross margin | 69.5% | 37.7% |
| Operating margin | 21.2% | 20.5% |
| Net margin | 17.3% | 17.0% |
| Return on equity | 13.6% | 18.9% |
| Return on assets | 8.0% | 13.9% |
| Return on invested capital | 11.5% | 17.5% |
| FCF yield | 5.0% | 1.8% |
| Dividend yield | — | 0.3% |
| Debt / equity | 0.00 | 0.07 |
| Current ratio | 1.90 | 2.82 |
| Altman Z (solvency) | 6.88 | 8.89 |
| Piotroski F (quality) | 5 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.